Early B-cell therapy linked to better MS disease control
For people recently diagnosed with multiple sclerosis (MS), early treatment choices were associated with only slight differences after…
Autoimmune diseases form distinct genetic clusters, study finds
Different autoimmune diseases often share genetic risk factors, but not through a single common genetic vulnerability. In a…
MS patients’ quality of life associated with walking performance and functional capacity
A study by the University of Eastern Finland found that quality of life in people with multiple sclerosis…
Emergency diagnoses of medical conditions predict worse patient survival
Patients diagnosed with conditions after an emergency hospital admission or an emergency room visit face a higher risk…
New blood protein biomarkers estimate timing of ALS symptoms
Months to several years before amyotrophic lateral sclerosis (ALS) symptoms arise, levels of certain blood proteins may dramatically…
Multiple sclerosis mortality trends underscore need for comprehensive patient care
An analysis of more than 42,000 U.S. deaths linked to multiple sclerosis (MS) found that death rates varied…
Novel salvage surgical approach for refractory multiple sclerosis-related trigeminal neuralgia
A case report in Chinese Neurosurgical Journal describes a novel salvage surgical approach for refractory multiple sclerosis-related trigeminal…
New gene therapy strategy uses the brain’s own glymphatic transport system for drug delivery
A new study describes a gene therapy strategy that uses the brain’s own glymphatic transport system to distribute…
Experimental drug shields nerve cells from damage caused by ALS
Amyotrophic Lateral Sclerosis, or ALS, received widespread awareness in the summer of 2014 thanks to an Ice Bucket…
Low-cost B-cell depleting therapy is as effective as standard treatment for multiple sclerosis
A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a…
Review finds vitamin D lacks disease-modifying effect in rheumatic diseases
A new review from the International Osteoporosis Foundation (IOF) Osteoimmunology Working Group, published in Osteoporosis International, provides a…
Ocrelizumab slows disability progression in advanced progressive multiple sclerosis
A major international phase III clinical trial, led by Queen Mary University of London, has found that ocrelizumab…